PHARMACODYNAMICS OF THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - CORRELATION WITH CHARACTERISTICS OF AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引：126
|
作者：
STUMP, DC
CALIFF, RM
TOPOL, EJ
SIGMON, K
THORNTON, D
MASEK, R
ANDERSON, L
COLLEN, D
机构：
[1] UNIV MICHIGAN, DEPT INTERNAL MED, DIV CARDIOL, ANN ARBOR, MI 48109 USA
[2] RIVERSIDE METHODIST HOSP, COLUMBUS, OH 43214 USA
[3] CHRIST HOSP, CINCINNATI, OH 45219 USA
[4] UNIV VERMONT, COLL MED, DEPT MED, BURLINGTON, VT 05405 USA
[5] UNIV VERMONT, COLL MED, DEPT BIOCHEM, BURLINGTON, VT 05405 USA
[6] DUKE UNIV, DEPT MED, DIV CARDIOL, DURHAM, NC 27706 USA
来源：
CIRCULATION | 1989年 / 80卷 / 05期
关键词：
D O I：
10.1161/01.CIR.80.5.1222
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1222 / 1230
页数：9
相关论文
共 50 条
  • [31] ARRHYTHMIAS AFTER RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    MCNEILL, AJ
    CUNNINGHAM, SR
    SHANNON, JS
    CAMPBELL, NPS
    KHAN, MM
    PATTERSON, GC
    WEBB, SW
    ADGEY, AAJ
    BRITISH HEART JOURNAL, 1988, 59 (01): : 136 - 137
  • [32] CLINICAL-PHARMACOLOGY IN PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PRODUCED BY RECOMBINANT DNA TECHNOLOGY
    TIEFENBRUNN, AJ
    ROBISON, AK
    KURNIK, PB
    LUDBROOK, PA
    SOBEL, BE
    CIRCULATION, 1985, 71 (01) : 110 - 116
  • [33] EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    HELD, PH
    TEO, KK
    YUSUF, S
    CIRCULATION, 1990, 82 (05) : 1668 - 1674
  • [34] CORONARY THROMBOLYSIS WITH HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TD-2061) IN PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION
    GOTO, Y
    KANEMOTO, N
    HIROSAWA, K
    KIMATA, S
    KAWAI, C
    YUI, Y
    YAMAMOTO, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1988, 52 (08): : 736 - 736
  • [35] EFFECTIVENESS OF MULTIPLE BOLUS ADMINISTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    KHAN, MI
    HACKETT, DR
    ANDREOTTI, F
    DAVIES, GJ
    REGAN, T
    HAIDER, AW
    MCFADDEN, E
    HALSON, P
    MASERI, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (16): : 1051 - 1056
  • [36] RANDOMIZED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION
    VERSTRAETE, M
    BORY, M
    COLLEN, D
    ERBEL, R
    LENNANE, RJ
    MATHEY, D
    MICHELS, HR
    SCHARTL, M
    UEBIS, R
    BERNARD, R
    BROWER, RW
    DEBONO, DP
    HUHMANN, W
    LUBSEN, J
    MEYER, J
    RUTSCH, W
    SCHMIDT, W
    VONESSEN, R
    LANCET, 1985, 1 (8433): : 842 - 847
  • [37] MONITORING OF FIBRIN GENERATION DURING THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    RAPOLD, HJ
    KUEMMERLI, H
    WEISS, M
    BAUR, H
    HAEBERLI, A
    CIRCULATION, 1989, 79 (05) : 980 - 989
  • [38] CORONARY PATENCY AFTER INTRAVENOUS-INFUSION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    BROWER, RW
    ARNOLD, AER
    LUBSEN, J
    VERSTRAETE, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (04) : 681 - 688
  • [39] CORONARY THROMBOLYSIS WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    GROSSBARD, E
    GOLD, H
    TIEFENBRUNN, A
    TOPOL, E
    BRINKER, J
    SPADARO, J
    LEINBACH, R
    YASUDA, H
    SOBEL, B
    WEISFELDT, M
    COLLEN, D
    CIRCULATION, 1984, 70 (04) : 27 - 27
  • [40] CORONARY THROMBOLYSIS - STREPTOKINASE OR RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    COLLEN, D
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (07) : 529 - 538
12345